Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2013 1
2016 1
2019 1
2021 1
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Nanomedicine based approaches for combating viral infections.
Shah S, Chougule MB, Kotha AK, Kashikar R, Godugu C, Raghuvanshi RS, Singh SB, Srivastava S. Shah S, et al. Among authors: kotha ak. J Control Release. 2021 Oct 10;338:80-104. doi: 10.1016/j.jconrel.2021.08.011. Epub 2021 Aug 8. J Control Release. 2021. PMID: 34375690 Free PMC article. Review.
Instigation of the epoch of nanovaccines in cancer immunotherapy.
Shah S, Famta P, Tiwari V, Kotha AK, Kashikar R, Chougule MB, Chung YH, Steinmetz NF, Uddin M, Singh SB, Srivastava S. Shah S, et al. Among authors: kotha ak. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1870. doi: 10.1002/wnan.1870. Epub 2022 Nov 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36410742 Review.
Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy.
Shah S, Famta P, Bagasariya D, Charankumar K, Sikder A, Kashikar R, Kotha AK, Chougule MB, Khatri DK, Asthana A, Raghuvanshi RS, Singh SB, Srivastava S. Shah S, et al. Among authors: kotha ak. Mol Pharm. 2022 Dec 5;19(12):4428-4452. doi: 10.1021/acs.molpharmaceut.2c00374. Epub 2022 Sep 15. Mol Pharm. 2022. PMID: 36109099 Review.
Safety and Pharmacokinetics of Intranasally Administered Heparin.
Harris HM, Boyet KL, Liu H, Dwivedi R, Ashpole NM, Tandon R, Bidwell GL 3rd, Cheng Z, Fassero LA, Yu CS, Pomin VH, Mitra D, Harrison KA, Dahl E, Gurley BJ, Kotha AK, Chougule MB, Sharp JS. Harris HM, et al. medRxiv [Preprint]. 2022 Feb 17:2021.07.05.21259936. doi: 10.1101/2021.07.05.21259936. medRxiv. 2022. PMID: 35194614 Free PMC article. Updated. Preprint.
Safety and Pharmacokinetics of Intranasally Administered Heparin.
Harris HM, Boyet KL, Liu H, Dwivedi R, Ashpole NM, Tandon R, Bidwell GL 3rd, Cheng Z, Fassero LA, Yu CS, Pomin VH, Mitra D, Harrison KA, Dahl E, Gurley BJ, Kotha AK, Chougule MB, Sharp JS. Harris HM, et al. Pharm Res. 2022 Mar;39(3):541-551. doi: 10.1007/s11095-022-03191-4. Epub 2022 Mar 2. Pharm Res. 2022. PMID: 35237922 Free PMC article.
13 results